Chlorzoxazone
- Product NDC
- 72336-225
- 11-digit product format
- 723360225
- Labeler code
- 72336
- Product ID
- 72336-225_b0267d20-0ac1-4809-a0d4-e8e8eb3f9127
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Chlorzoxazone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Lifsa Drugs LLC
- Application
- ANDA214702
- Marketing category
- ANDA
- Marketing start
- 2025-03-20
- Substance
- CHLORZOXAZONE
- Active strength
- 250 mg/1
- Pharmacologic classes
- Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Chlorzoxazone
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| CHLORZOXAZONE | 250 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | H0DE420U8G |
| Rxcui | 197501 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72336-225-60 | Chlorzoxazone | 60 in 1 BOTTLE | TABLET | 60 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 72336-225 | CHLORZOXAZONE TABLET [LIFSA DRUGS LLC] | 1 | Current NDC, 1 package rows | 20250406_0f222059-1ece-44f3-ae7f-d277e5bcaba4.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72336-225-60 | 72336022560 | 60 TABLET in 1 BOTTLE (72336-225-60) | 60 tablet | 2025-03-20 | No | No | Historical |